De Luna, Marilou M.

HRN: 23-39-08  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/01/2023
CEFUROXIME 1.5GM (VIAL)
09/01/2023
09/02/2023
IV
1.5g
Q8
Ltcs
Waiting Final Action 
09/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/01/2023
09/02/2023
IV
500
Q8
Ltcs W/ Iud
Waiting Final Action 
09/02/2023
CEFUROXIME 500MG (TAB)
09/02/2023
09/09/2023
ORAL
500mg
BID
Ltcs
Waiting Final Action 
09/02/2023
METRONIDAZOLE 500MG (TAB)
09/02/2023
09/09/2023
ORAL
500mg
BID
Ltcs Tmsaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: